Bot Detector
Download FREE Sample Issue or Article
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Pluronic Lecithin Organogel for Local Delivery of Anti-Inflammatory Drugs

Author(s):  Frankum James, Ramsay Dale, Das Nandita G, Das Sudip K

Issue:  Mar/Apr 2004 - Overview of USP Chapter <797>
View All Articles in Issue

Page(s):  101-105

Download in electronic PDF format for $65

Abstract:  The authors begin with a rationalization for a vehicle such as Pluronic lecithin organogel: the need to find a method of administering analgesics and pain medications for local pain relief that minimizes systemic side effects. They then discuss the mechanism of pain, drugs used to treat pain, Pluronic lecithin organogel as a vehicle for delivering topical analgesia, the ability of Pluronic lecithin organogel to enhance bioavailability of drugs, clinical studies with topical nonsteroidal anti-inflammatory drugs, pharmacokinetics of nonsteroidal anti-inflammatory drugs following topical application, side effects, and instructions for use. They conclude that Pluronic lecithin organogel provides a topical vehicle base for delivery of analgesic drugs that can supplant injection or oral administration, with the advantages of significant reduction of severe side effects, increased patient compliance and increase of potential analgesic effects at the painful site. They note that this dosage form can have side effects such as local irritation and may not be appropriate for use with all drugs. Despite these reservations, the authors suggest that Pluronic lecithin organogel appears to be effective as an alternative method for delivery of pain relief, for both patient and practitioner.

Related Keywords: Anti-inflammatory drugs, PLO as vehicle for, Das, Nandita G, PhD, MPharm, RPh, Das, Sudip K, PhD, MPharm, Frankum, James, PharmD, Nonsteroidal anti-inflammatory drugs, in PLO, NSAIDs, in PLO, PLO, for anti-inflammatory drugs, Pluronic lecithin organogel, and anti-inflammatory drugs, as vehicle for, Ramsay, Dale, PharmD


Printer-Friendly Version

Related Articles from IJPC
(Click for Abstract / Details)
Pluronic Lecithin Organogel for Local Delivery of Anti-Inflammatory Drugs
Frankum James
, Ramsay Dale, Das Nandita G, Das Sudip K
Mar/Apr 2004
Pg. 101-105

The History of Pluronic Lecithin Organogel: An Interview With Marty Jones, BSPharm, FACA, FIACP
Allen Loyd V Jr
May/Jun 2003
Pg. 180-183

Enhancement of Skin Penetration of Nonsteroidal Anti-Inflammatory Drugs from Extemporaneously Compounded Topical-Gel Formulations
Goodwin Donald A
, Fuhram L Clifton
Nov/Dec 1999
Pg. 496-500

Ketoprofen 10% in Pluronic Lecithin Organogel
Allen Loyd V Jr
Jan/Feb 2019
Pg. 52

BHR in PLO Gel (Benadryl, Haldol, and Reglan in Pluronic Lecithin Organogel)
Allen Loyd V Jr
Jul/Aug 2021
Pg. 322

Veterinary Antibiotic/Antifungal/Anti-Inflammatory Anesthetic Otic Drop
Allen Loyd V Jr
May/Jun 1999
Pg. 225

Veterinary Antibiotic/Antifungal/Anti-Inflammatory Anesthetic Otic Drops
Hinkle Amanda R
, Newton Gail D
May/Jun 2004
Pg. 185

Transdermal Administration of Anti-inflammatory Medications in Sports Injuries: Use of Iontophoresis and Phonophoresis to Enhance Delivery
Heim Bob
Jan/Feb 2006
Pg. 14-18

View Sample
Bioavailability of Promethazine in a Topical Pluronic Lecithin Organogel: A Pilot Study
Glisson James K
, Wood Rebecca L, Kyle Patrick B, Cleary John D
May/Jun 2005
Pg. 242-246

Physical Stability and Release Profile of Compounded Gabapentin Containing Pluronic Lecithin Organogel for Neuropathic Pain Management
Hong Eun Ji
, Sumanasekera Wasana, Le Uyen Minh
Jan/Feb 2022
Pg. 65-71

Particle Measuring Systems - USP <797> Environmental Monitoring Solutions